Published in

Dove Press, Drug Design, Development and Therapy, (Volume 16), p. 2933-2948, 2022

DOI: 10.2147/dddt.s380925

Links

Tools

Export citation

Search in Google Scholar

Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO